Go back to Resources
Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers
2001
Journal Article
Authors:
Secondary:
J Infec Dis
Volume:
183
Pagination:
1343-52